Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist
Open Access
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8749) , 1062-1063
- https://doi.org/10.1016/0140-6736(91)91709-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Inhibition of Leukotriene D4-induced Bronchoconstriction in Normal Subjects by the Oral LTD4Receptor Antagonist ICI 204,219American Review of Respiratory Disease, 1990
- The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene AntagonistAmerican Review of Respiratory Disease, 1990
- A Specific LTD4/LTE4receptor Antagonist Improves Pulmonary Function in Patients with Mild, Chronic AsthmaAmerican Review of Respiratory Disease, 1989
- Effect of the oral leukotriene D antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D in atopic subjectsJournal of Allergy and Clinical Immunology, 1989
- The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma*1Journal of Allergy and Clinical Immunology, 1987
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983